Home / HEALTH / COVID-19: FDA Approves First Herbal Medicine For Clinical Trial

COVID-19: FDA Approves First Herbal Medicine For Clinical Trial

Spread the love


The regulatory agency has approved local medicine ‘Cryptolepis Sanguinolenta’, popularly known as Nibima, for clinical trial on COVID-19 treatment

The Food and Drugs Authority (FDA) has approved Ghana’s first herbal medicine for clinical trial on COVID-19 treatment.

This follows results from laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team.

This means the medicine, Cryptolepis Sanguinolenta, locally known as Nibima stands a better chance of being used to treat COVID-19 if it is approved after the trial.

See also  Covid-19: Delta Strain Kills 10 Persons Within 2-Weeks In Kumasi

A statement signed and released by FDA CEO Delese Darko said the authority remains committed to protect the health and safety of consumers.

Below is the full statement:


Case update 

At least 416 COVID-19 deaths have been confirmed by the Ghana Health Service. The country has also recorded a total of 67,010 confirmed cases and 61,236 recoveries. Active cases stand at 5,358.

Source: Asaaseradio.com

Disclaimer: MyGhanaMedia is not responsible for this report and its content.There are four types of content published on MyGhanaMedia daily: curated content; syndicated content; user-generated content; and original content.

Send your news stories to myghan[email protected] and Chat with us via WhatsApp on +233 200818719

About Adwenpa-Hene

I'm Adwenpa-Hene |Blogger & Broadcaster Journalist. I am the CEO and manager of this noble website. I publish on Entertainment, Sports, Politics, Lifestyle, and Technology. You can also follow Us on : YouTube Channel - My Ghana Media TV, Facebook - MyghanaMedia TV , Twitter - @MyGhanamedia2 & Instagram - My Ghana Media TV. Email Address: [email protected] Contact Us: 0200818719

Check Also

Rotational Nurses And Midwives Threaten Strike Over Unpaid Allowances

Spread the love The Rotational Nurses and Midwives Association is urging the Nurses and Midwifery …

Leave a Reply

Your email address will not be published. Required fields are marked *